Sarah Bos

35 Hemostatic profiles are similar across all etiologies of cirrhosis. 2 33. Violi F, Ferro D, Quintarelli C, et al. Dilute aPTT prolongation by antiphospholipid antibodies in patients with liver cirrhosis. Thromb Haemost. 1990;63(2):183-186. 34. Quintarelli C, Ferro D, Valesini G, Basili S, Tassone G, Violi F. Prevalence of lupus anticoagulant in patients with cirrhosis: relationship with beta-2-glycoprotein I plasma levels. J Hepatol. 1994;21(6):1086-1091. 35. Lisman T, Ariëns RAS. Alterations in Fibrin Structure in Patients with Liver Diseases. Semin Thromb Hemost. 2016;42(4):389-396. 36. Goodpasture EW. Fibrinolysis in chronic hepatic insufficiency. Johns Hopkins Hosp Bull. 1914;25:330-336. 37. Lisman T, Kleiss SF, Patel V, et al. In vitro efficacy of pro- and anticoagulant strategies in compensated and acutely ill patients with cirrhosis. Liver Int. 2018:1-9.